HS-20093, a B7-H3-targeted antibody-drug conjugate in lung cancer: Results from the ARTEMIS-001 phase 1a/b trial

Journal:
Cancer Cell
Published:
Affiliations:
26
Authors:
28
Institutions Authors Share
Jiangsu Hansoh Pharmaceutical Group Co., Ltd., China
6.000000
0.21
Shandong Cancer Hospital, China
2.000000
0.07
Hunan Cancer Hospital, China
2.000000
0.07
Xuzhou Central Hospital (XZCH), China
1.000000
0.04
Harbin Medical University Cancer Hospital, China
1.000000
0.04
The First Affiliated Hospital of Xinxiang Medical University, China
1.000000
0.04
The First Affiliated Hospital of Gannan Medical University, China
1.000000
0.04
Zhejiang Cancer Hospital (ZJCH), China
1.000000
0.04
Zhongnan Hospital, WHU, China
1.000000
0.04
Yuebei People's Hospital, China
1.000000
0.04
Hubei Cancer Hospital (HBCH), China
1.000000
0.04
Jilin Province Cancer Hospital, China
1.000000
0.04
Jiamusi Tumor Hospital, China
1.000000
0.04
Taizhou Hospital of Zhejiang Province, China
1.000000
0.04
The First Affiliated Hospital of Henan University of Science and Technology, China
1.000000
0.04
Affiliated Hospital of SDMPU, China
1.000000
0.04
Fujian Cancer Hospital, China
1.000000
0.04
Sichuan Cancer Hospital, China
1.000000
0.04
Shanxi Cancer Hospital, China
0.833333
0.03
State Key Laboratory of Molecular Oncology, China
0.833333
0.03
Henan Cancer Hospital, ZZU, China
0.500000
0.02
Henan Academy of Innovations in Medical Science, China
0.500000
0.02
Cancer Institute and Hospital, CAMS & PUMC, China
0.333333
0.01